These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 4788375

  • 1. The pharmacology of cyanate with a summary of its initial usage in sickle cell disease.
    Gillette PN, Lu YS, Peterson CM.
    Prog Hematol; 1973; 8():181-90. PubMed ID: 4788375
    [No Abstract] [Full Text] [Related]

  • 2. Cyanate as an inhibitor of red-cell sickling.
    Cerami A.
    N Engl J Med; 1972 Oct 19; 287(16):807-12. PubMed ID: 4560520
    [No Abstract] [Full Text] [Related]

  • 3. The clinical use of cyanate in sickling.
    Ranney HM.
    N Engl J Med; 1972 Jul 13; 287(2):98-100. PubMed ID: 4624186
    [No Abstract] [Full Text] [Related]

  • 4. Sodium cyanate as a potential treatment for sickle-cell disease.
    Gillette PN, Peterson CM, Lu YS, Cerami A.
    N Engl J Med; 1974 Mar 21; 290(12):654-60. PubMed ID: 4813727
    [No Abstract] [Full Text] [Related]

  • 5. Clinical evaluation of cyanate in sickle cell anemia.
    Harkness DR, Roth S.
    Prog Hematol; 1975 Mar 21; 9():157-84. PubMed ID: 766071
    [No Abstract] [Full Text] [Related]

  • 6. Gas chromatographic determination of the carbamylation of hemoglobin S by cyanate.
    Manning JM, Lee CK, Cerami A, Gillette PN.
    J Lab Clin Med; 1973 Jun 21; 81(6):941-5. PubMed ID: 4710373
    [No Abstract] [Full Text] [Related]

  • 7. Effects of urea and cyanate on sickling in vitro.
    Segel GB, Feig SA, Mentzer WC, McCaffrey RP, Wells R, Bunn HF, Shohet SB, Nathan DG.
    N Engl J Med; 1972 Jul 13; 287(2):59-64. PubMed ID: 5031386
    [No Abstract] [Full Text] [Related]

  • 8. Review of the development of cyanate as a drug in the treatment of sickle cell anemia.
    Cerami A.
    Ann N Y Acad Sci; 1974 Nov 29; 241(0):538-44. PubMed ID: 4611307
    [No Abstract] [Full Text] [Related]

  • 9. Therapy of sickle cell disease: an approach with sodium cyanate.
    Peterson CM, Cerami A.
    Semin Hematol; 1974 Oct 29; 11(4):569-76. PubMed ID: 4213637
    [No Abstract] [Full Text] [Related]

  • 10. Determination of the blood concentrations of cyanate after intravenous administration to patients with sickle-cell disease.
    Nigen AM, Peterson CM, Gillette PN, Manning JM.
    J Lab Clin Med; 1974 Jan 29; 83(1):139-46. PubMed ID: 4808651
    [No Abstract] [Full Text] [Related]

  • 11. Red cell survival of cyanate reacted sickle cells.
    Bellingham AJ, May A, Huehns ER.
    Clin Sci; 1972 Apr 29; 42(4):21P. PubMed ID: 5020279
    [No Abstract] [Full Text] [Related]

  • 12. Cyanate effect on sickling.
    Charache S, Milner PF.
    N Engl J Med; 1972 Dec 28; 287(26):1357-8. PubMed ID: 4635027
    [No Abstract] [Full Text] [Related]

  • 13. Urea, cyanate and sickling.
    Harris A.
    N Engl J Med; 1971 Sep 16; 285(12):690-1. PubMed ID: 5563487
    [No Abstract] [Full Text] [Related]

  • 14. Cyanate and sickling.
    Charache S, Diederich D.
    N Engl J Med; 1971 Nov 11; 285(20):1147. PubMed ID: 5095746
    [No Abstract] [Full Text] [Related]

  • 15. Carbamylation of the chains of hemoglobin S by cyanate in vitro and in vivo.
    Njikam N, Jones WM, Nigen AM, Gillette PN, Williams RC, Manning JM.
    J Biol Chem; 1973 Dec 10; 248(23):8052-6. PubMed ID: 4752945
    [No Abstract] [Full Text] [Related]

  • 16. The effect of hemoglobin carbamylation on the survival of human sickle cell erythrocytes in rats.
    Castro O, Orlin J, Finch SC.
    Yale J Biol Med; 1974 Mar 10; 47(1):55-60. PubMed ID: 4825087
    [No Abstract] [Full Text] [Related]

  • 17. Cyanate and sickle-cell disease.
    Cerami A, Peterson CM.
    Sci Am; 1975 Apr 10; 232(4):44-50. PubMed ID: 1114310
    [No Abstract] [Full Text] [Related]

  • 18. Extracorporeal treatment of blood with cyanate in primates: physiologic and toxicologic observations.
    Papayannopoulou T, Finch CA, Stamatoyannopoulos G, Hlastala MP.
    J Lab Clin Med; 1974 Jul 10; 84(1):81-91. PubMed ID: 4833845
    [No Abstract] [Full Text] [Related]

  • 19. Continuous extracorporeal chemotherapy of blood utilizing hemodialysis: potential for the treatment of sickle cell disease.
    Kjellstrand CM, Shideman JR, Eaton JW.
    Trans Am Soc Artif Intern Organs; 1974 Jul 10; 20 B():574-8. PubMed ID: 4450307
    [No Abstract] [Full Text] [Related]

  • 20. Preliminary studies of continuous extracorporeal carbamylation in the treatment of sickle cell anemia.
    Balcerzak SP, Grever MR, Sing DE, Bishop JN, Segal ML.
    J Lab Clin Med; 1982 Sep 10; 100(3):345-55. PubMed ID: 7108349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.